SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-22-070510
Filing Date
2022-06-13
Accepted
2022-06-13 16:01:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm2217745-3_424b3.htm 424B3 476609
2 GRAPHIC lg_nrx-4clr.jpg GRAPHIC 44547
  Complete submission text file 0001104659-22-070510.txt   539201
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-264201 | Film No.: 221011586
SIC: 2834 Pharmaceutical Preparations